SILVER SPRING, Md., Feb. 26, 2021 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Nulibry (fosdenopterin) for injection to reduce the risk of death due to Molybdenum Cofactor Deficiency Type A, a rare, genetic, metabolic disorder that typically presents in the first...
from PR Newswire: https://ift.tt/3bMv5lN
No comments:
Post a Comment